A fully-automated bioreactor to culture human-induced pluripotent stem cells (hiPSCs) long-term has been developed by researchers at the Fraunhofer Translational Center for Regenerative Therapies.

Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), today announced the completion of its ballroom-style cleanroom, featuring a state-of-the-art ...

Southwest Research Institute (SwRI) has demonstrated a new application for its cell-expansion bioreactor to advance tissue engineering and cell-based therapies for treatment of injuries and diseases.

Independent Control of up to 24 Cultures for Scalable, Closed-System Cell Therapy Development CAMARILLO, Calif., Dec. 2, 2025 /PRNewswire/ -- PBS Biotech ("PBS"), a leader in single-use bioreactor ...

BETHLEHEM, Pa.--(BUSINESS WIRE)--ABEC, a global leader in engineered solutions and services for biotech manufacturing, has introduced its Advanced Therapy Bioreactor (ATB™) – a revolutionary platform ...

Southwest Research Institute (SwRI) has demonstrated a new application for its cell-expansion bioreactor to advance tissue engineering and cell-based therapies for treatment of injuries and diseases.

A novel approach to automating cell therapy manufacturing using industry-standard equipment can potentially reduce human errors, deliver higher quality product, and lower manufacturing costs by ...

A cell-culturing technique developed by KAUST scientists helps to create biological conditions that more closely mirror physiological environments compared to standard protocols used in most ...

Southwest Research Institute demonstrated its single-use 3D bioreactor to produce induced Pluripotent Stem Cells (iPSCs), derived from adult skin, blood, and other somatic cells. Useful for ...